Back to Results
First PageMeta Content
Health / Clinical pharmacology / Drug discovery / Pharmaceuticals policy / MODDERN Cures Act / Pharmaceutical industry / Dormant Therapy / Orphan drug / Food and Drug Administration / Pharmaceutical sciences / Pharmacology / Clinical research


Testimony of Marc Boutin, JD Executive Vice President and Chief Operating Officer National Health Council 21st Century Cures Initiative Hearing - June 11, 2014 House Committee on Energy and Commerce
Add to Reading List

Document Date: 2014-06-11 11:20:35


Open Document

File Size: 417,18 KB

Share Result on Facebook

Company

Texas Law Review / William Mitchell Law Review / JD / /

Country

United States / /

/

IndustryTerm

biotechnology / pharmaceutical industry / prevention of various diseases / insurance / pharmaceutical / /

MedicalCondition

rare diseases / chronic condition / Lou Gehrig’s disease / cancer / later-stage cancers / disease / later cancer / ALS / longterm disease / early-stage disease / mesothelioma / chronic disease / multiple sclerosis / diseases / chronic diseases / epilepsy / lupus / /

Organization

Congress / House Committee on Energy and Commerce / Chief Operating Officer National Health Council / FDA / Bureau of Economic Research / National Health Council / Medicare / /

Person

Leonard Lance / Michael Gollin / Henry Waxman / Orrin Hatch / Lou Gehrig / Marc Boutin / /

/

Position

patent attorney / physician / Executive Vice President / Representative / /

ProgrammingLanguage

DC / /

PublishedMedium

Texas Law Review / the William Mitchell Law Review / /

Technology

Alpha / pharmacogenetics / diagnostic tests / biotechnology / drug development / /

URL

http /

SocialTag